GlaxoSmithKline buys 10% of German vaccine maker

The companies plan to develop up to five infectious disease therapies, but a potential Covid-19 vaccine is not on the list.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.